Abstract:Objective: This guideline provides an update on the care of pregnant women living with HIV and the prevention of perinatal HIV transmission. This guideline is a revision of the previous guideline, No. 310 Guidelines for the Care of Pregnant Women Living With HIV and Interventions to Reduce Perinatal Transmission, and includes an updated review of the literature with contemporary recommendations. Target population: Pregnant women newly diagnosed with HIV during antenatal screening and women living with HIV who become pregnant. This guideline does not include specific guidance for girls/women of reproductive age living with HIV who are not pregnant. Outcomes: Prevention of perinatal HIV transmission is a key indicator of the success of a health care system and requires multidisciplinary care of pregnant women living with HIV. Intended outcomes include guidance on best practice in perinatal management for Canadian health care providers for pregnant women living with HIV; reduction of perinatal transmission of HIV toward a target of eradication of perinatal transmission; provision of optimal antenatal care for pregnant women to ensure the best maternal health outcomes and HIV suppression; and evidence-based support and recommendations for pregnant women living with HIV, maintaining awareness and consideration of the complex psychosocial impacts of living with HIV. Benefits, harms, and costs: The perinatal transmission of HIV has significant morbidity and mortality implications for the child, with associated lifelong health care costs. Pregnancy presents an emotionally and physically vulnerable time for pregnant women as well as an opportunity to engage them in health promotion. This guidance does not include recommendations with additional costs to health care facilities compared with the previous guideline. Application of the recommendations is aimed at health benefits to both mother and child by optimizing maternal health and preventing perinatal HIV transmission. Evidence: Published and unpublished literature was reviewed with a focus on publications post-2013. OVID-Medline, Embase, PubMed and the Cochrane Library databases were searched for relevant publications available in English or French for each section of this guideline. Results included systematic reviews, randomized controlled trials, and observational studies published from 2012 to 2022. Searches were updated on a regular basis and incorporated in the guideline until May 2023. Unpublished literature, protocols, and international guidelines were identified by accessing the websites of health-related agencies, clinical practice guideline collections, and national and international medical specialty societies. Validation methods: The authors rated the quality of evidence and strength of recommendations using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. See Appendix A (Tables A1 for definitions and A2 for interpretations of strong and conditional recommendations). Intended audience: The intended users of this guideline include obstetric care providers and infectious disease clinicians who provide care for pregnant women living with HIV. Social media summary: Updated Canadian HIV in pregnancy guideline informed by global research and tailored to Canadian healthcare needs and goals for pregnant women living with HIV and their families. Summary statements: RECOMMENDATIONS.

Advances in HIV Management During Pregnancy and Infant Feeding

Clinical Trials That Have Changed Clinical Practice and Care of Pregnant People With HIV

Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy

Parenting with HIV: a patient's view on updated infant feeding guidelines in the US

Interventions to Improve Antiretroviral Adherence in HIV-infected Pregnant Women: A Systematic Review and Meta-Analysis

Implementation of Updated HIV Infant Feeding Guidelines and Lessons Learned

Preventing perinatal HIV acquisition; current gaps and future perspectives

Facilitators and Barriers to Adherence to Anti-Retroviral Treatment Among Pregnant or Breastfeeding Women Living with HIV and Perinatally Infected Infants: A Scoping Review

How women living with HIV in the UK manage infant-feeding decisions and vertical transmission risk - a qualitative study

New US DHHS Guidelines for Feeding of HIV Exposed Infants: Uptake, Practice Variability and Concerns

Guideline No. 450: Care of Pregnant Women Living with HIV and Interventions to Reduce Perinatal Transmission

Safety of Antiretroviral Exposure during Pregnancy: Opportunities to Close Data Gaps

Development and Implementation of an Interdisciplinary Model for the Management of Breastfeeding in Women With HIV in the United States: Experience From the Children's Hospital Colorado Immunodeficiency Program

A Review of Updated Guidelines on Breastfeeding with Human Immunodeficiency Virus Using Relational Decision-Making and Intellectual Humility to Support Infant Feeding Choices

Prevention of HIV transmission from mother to child

Antiretroviral Therapy in Pregnancy: A 2023 Review of the Literature

Breastfeeding in women with HIV infection: A qualitative study of barriers and facilitators

Risk of transmission of HIV to infants during breast/chest feeding when mothers/birthing parents living with HIV are on antiretroviral therapy: a protocol for a rapid review

Prophylaxis and treatment of HIV infection in pregnancy, Swedish guidelines 2024

In Support of Breast/Chest Feeding by People with HIV in High-Income Settings

Eliminating postnatal HIV transmission in high incidence areas: need for complementary biomedical interventions